Novavax Inc (NVV1)

Currency in EUR
6.70
+0.57(+9.30%)
Closed·
Unusual trading volume
Fair Value
Day's Range
6.056.78
52 wk Range
4.5516.33
Key Statistics
Bid/Ask
6.61 / 6.68
Prev. Close
6.14
Open
6.19
Day's Range
6.05-6.78
52 wk Range
4.55-16.33
Volume
205.27K
Average Volume (3m)
53.02K
1-Year Change
-55.31%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NVV1 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Novavax Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Novavax Inc Company Profile

Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Compare NVV1 to Peers and Sector

Metrics to compare
NVV1
Peers
Sector
Relationship
P/E Ratio
0.0x−4.7x−0.5x
PEG Ratio
0.000.020.00
Price/Book
0.0x3.5x2.6x
Price / LTM Sales
0.0x8.5x3.2x
Upside (Analyst Target)
0.0%50.9%42.7%
Fair Value Upside
Unlock4.5%5.8%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

NVV1 Income Statement

People Also Watch

7.932
BBAI
+7.63%
43.28
IONQ
+3.20%
16.140
RGTI
+4.60%
49.170
RKLB
+4.88%
66.97
OKLO
+9.21%

FAQ

What Stock Exchange Does Novavax Inc Trade On?

Novavax Inc is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for Novavax Inc?

The stock symbol for Novavax Inc is "NVV1."

What Is the Novavax Inc Market Cap?

As of today, Novavax Inc market cap is 1.09B.

What Is Novavax Inc's Earnings Per Share (TTM)?

The Novavax Inc EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is NVV1 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Novavax Inc Stock Split?

Novavax Inc has split 0 times.

What is the current trading status of Novavax Inc (NVV1)?

As of 23 Jul 2025, Novavax Inc (NVV1) is trading at a price of 6.70, with a previous close of 6.14. The stock has fluctuated within a day range of 6.05 to 6.78, while its 52-week range spans from 4.55 to 16.33.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.